EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Novel neoadjuvant immunochemotherapy followed by surgical resection for intrathyroidal thymic carcinoma: a case report and literature review

Wencong Sun, Zhaoyang Shang, Zijie Su, Xinhui Wang, Chuangxin Lu, Guoqing Li, Zhenhua Zhang

Frontiers in Oncology · 18.11.2026 · 16

DOI: 10.3389/fonc.2026.1818294 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 18.11.2026. Verfasst von Wencong Sun und 6 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intrathyroidal thymic carcinoma (ITC) is an exceptionally rare and aggressive malignancy. Due to its rarity and overlapping features with other thyroid cancers, standardized treatment protocols for advanced, locally invasive ITC are lacking. This report presents a case of locally advanced ITC with tracheoesophageal invasion, successfully treated with a novel multimodal approach centered on neoadjuvant immunochemotherapy. Case presentation A 47-year-old male presented with a right cervical mass exhibiting progressive growth and local invasion on imaging. Core needle biopsy and comprehensive immunohistochemical profiling confirmed the diagnosis of ITC (squamous cell carcinoma), with a PD-L1 CPS of 3. After initial consultation, the patient subsequently received a novel neoadjuvant regimen combining pembrolizumab, albumin-bound paclitaxel, and carboplatin for four cycles. This treatment resulted in significant tumor shrinkage, enabling a subsequent extended radical thyroidectomy. Pathological examination of the resected specimen confirmed a partial pathological response with focal residual disease and limited nodal metastasis. The treatment course was consolidated with postoperative adjuvant radiotherapy.

Conclusion

This case demonstrates that neoadjuvant immunochemotherapy can be a highly effective and feasible strategy for downsizing locally advanced ITC, thereby converting inoperable tumors into resectable ones. The successful application of this multimodal regimen, culminating in a favorable pathological response and successful surgical resection, provides a valuable paradigm for managing this challenging disease. Our experience suggests that this innovative approach warrants further investigation as a potential new standard of care for selected patients with advanced ITC.

Zitieren

APA

Sun, W., Shang, Z., Su, Z., Wang, X., Lu, C., Li, G., & Zhang, Z. (2026). Novel neoadjuvant immunochemotherapy followed by surgical resection for intrathyroidal thymic carcinoma: a case report and literature review. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1818294

Vancouver

Sun W, Shang Z, Su Z, Wang X, Lu C, Li G, et al. Novel neoadjuvant immunochemotherapy followed by surgical resection for intrathyroidal thymic carcinoma: a case report and literature review. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1818294

BibTeX
@article{Sun2026,
  author = {Sun, Wencong and Shang, Zhaoyang and Su, Zijie and Wang, Xinhui and Lu, Chuangxin and Li, Guoqing and Zhang, Zhenhua},
  title = {Novel neoadjuvant immunochemotherapy followed by surgical resection for intrathyroidal thymic carcinoma: a case report and literature review},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1818294}
}
Kostenlos starten →